Moderna and Merck & Co. have developed a cancer vaccine that cuts the risk of death or recurrence of most deadly skin cancer by 44 percent compared to Merck's Keytruda on its own, according to researchers. 

Share:
More In Science
FDA Warns Against Contaminated Eye Drops
The Food and Drug Administration issued a warning about two brands of eye drops being sold online that they both have potential fungal and bacterial contamination.
Load More